These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30396926)

  • 1. Modified Nucleosides - Molecular Markers Suitable for Small-volume Cancer?
    Opitz P; Herbarth O; Seidel A; Boehm A; Fischer M; Mozet C; Dietz A; Wichmann G
    Anticancer Res; 2018 Nov; 38(11):6113-6119. PubMed ID: 30396926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified nucleosides as biomarkers for early cancer diagnose in exposed populations.
    Seidel A; Seidel P; Manuwald O; Herbarth O
    Environ Toxicol; 2015 Jul; 30(8):956-67. PubMed ID: 24615900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The volatilome - investigation of volatile organic metabolites (VOM) as potential tumor markers in patients with head and neck squamous cell carcinoma (HNSCC).
    Opitz P; Herbarth O
    J Otolaryngol Head Neck Surg; 2018 Jul; 47(1):42. PubMed ID: 29970175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of urinary nucleosides by high-performance liquid chromatography.
    Liebich HM; Di Stefano C; Wixforth A; Schmid HR
    J Chromatogr A; 1997 Feb; 763(1-2):193-7. PubMed ID: 9129323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control.
    Seidel A; Brunner S; Seidel P; Fritz GI; Herbarth O
    Br J Cancer; 2006 Jun; 94(11):1726-33. PubMed ID: 16685264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multilayer perceptron tumour diagnosis based on chromatography analysis of urinary nucleosides.
    Seidel P; Seidel A; Herbarth O
    Neural Netw; 2007 Jul; 20(5):646-51. PubMed ID: 17275256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial neural network classification based on high-performance liquid chromatography of urinary and serum nucleosides for the clinical diagnosis of cancer.
    Yang J; Xu G; Kong H; Zheng Y; Pang T; Yang Q
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(1):27-33. PubMed ID: 12383477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers.
    Gross ND; Boyle JO; Morrow JD; Williams MK; Moskowitz CS; Subbaramaiah K; Dannenberg AJ; Duffield-Lillico AJ
    Clin Cancer Res; 2005 Aug; 11(16):6087-93. PubMed ID: 16115954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancer.
    Bullinger D; Fröhlich H; Klaus F; Neubauer H; Frickenschmidt A; Henneges C; Zell A; Laufer S; Gleiter CH; Liebich H; Kammerer B
    Anal Chim Acta; 2008 Jun; 618(1):29-34. PubMed ID: 18501242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated levels of 1-hydroxypyrene and N'-nitrosonornicotine in smokers with head and neck cancer: A matched control study.
    Khariwala SS; Carmella SG; Stepanov I; Fernandes P; Lassig AA; Yueh B; Hatsukami D; Hecht SS
    Head Neck; 2013 Aug; 35(8):1096-100. PubMed ID: 22807150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary nucleosides as potential tumor markers evaluated by learning vector quantization.
    Dieterle F; Müller-Hagedorn S; Liebich HM; Gauglitz G
    Artif Intell Med; 2003 Jul; 28(3):265-79. PubMed ID: 12927336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
    Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary modified nucleosides as novel biomarkers for diagnosis and prognostic monitoring of urothelial bladder cancer.
    Zhang YR; Shi L; Wu H; Tang DD; Wang SM; Liu HM; Zhang LR; Song DK
    Tumori; 2014; 100(6):660-6. PubMed ID: 25688500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method.
    Xu G; Schmid HR; Lu X; Liebich HM; Lu P
    Biomed Chromatogr; 2000 Nov; 14(7):459-63. PubMed ID: 11113924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabonomics in cancer diagnosis: mass spectrometry-based profiling of urinary nucleosides from breast cancer patients.
    Frickenschmidt A; Frohlich H; Bullinger D; Zell A; Laufer S; Gleiter CH; Liebich H; Kammerer B
    Biomarkers; 2008 Jun; 13(4):435-49. PubMed ID: 18484357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversed-phase high-performance liquid chromatographic investigation of urinary normal and modified nucleosides of cancer patients.
    Xu G; Di Stefano C; Liebich HM; Zhang Y; Lu P
    J Chromatogr B Biomed Sci Appl; 1999 Sep; 732(2):307-13. PubMed ID: 10517352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two approaches for determining the urinary excretion patterns of nucleosides--HPLC and CE.
    Xu G; Lu X; Zhang Y; Lu P; Di Stefano C; Lehmann R; Liebich H
    Se Pu; 1999 Mar; 17(2):97-101. PubMed ID: 12549143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of urinary excretion of modified nucleosides.
    Gehrke CW; Kuo KC; Waalkes TP; Borek E
    Cancer Res; 1979 Apr; 39(4):1150-3. PubMed ID: 421198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of RP-HPLC columns used for determination of nucleoside metabolic patterns in urine of cancer patients.
    Waszczuk-Jankowska M; Markuszewski MJ; Markuszewski M; Kaliszan R
    Bioanalysis; 2012 Jun; 4(10):1185-94. PubMed ID: 22651562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of urinary nucleosides excretion of intestinal cancer patients by reversed-phase high performance liquid chromatography].
    Zheng YF; Chen YJ; Pang T; Shi XZ; Kong HW; Lü S; Yang Q; Xu GW
    Se Pu; 2002 Nov; 20(6):498-501. PubMed ID: 12682995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.